RLF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.458420E-01
Normal-vs-Stage2
4.293800E-01
Normal-vs-Stage3
9.574200E-02
Normal-vs-Stage4
4.662800E-01
Stage1-vs-Stage2
3.753800E-01
Stage1-vs-Stage3
2.587000E-01
Stage1-vs-Stage4
6.837900E-03
Stage2-vs-Stage3
9.545700E-02
Stage2-vs-Stage4
6.810200E-02
Stage3-vs-Stage4
7.135300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.269000E-01
Normal-vs-AfricanAmerican
8.088600E-01
Normal-vs-Asian
4.313800E-01
Caucasian-vs-AfricanAmerican
4.035800E-01
Caucasian-vs-Asian
8.210600E-01
AfricanAmerican-vs-Asian
5.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.466400E-01
Normal-vs-Female
3.843800E-01
Male-vs-Female
4.909200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.553800E-01
Normal-vs-Age(41-60Yrs)
8.154000E-01
Normal-vs-Age(61-80Yrs)
2.466600E-01
Normal-vs-Age(81-100Yrs)
6.410500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.809000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.427600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.385200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.806400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.609100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.233980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.389800E-01
Normal-vs-Daily Drinker
2.120200E-01
Normal-vs-Weekly Drinker
1.559010E-01
Normal-vs-Occasional Drinker
5.010400E-01
Normal-vs-Social Drinker
4.819400E-01
Non Drinker-vs-Daily Drinker
9.485400E-01
Non Drinker-vs-Weekly Drinker
7.830000E-01
Non Drinker-vs-Occasional Drinker
2.225400E-01
Non Drinker-vs-Social Drinker
1.990010E-01
Daily Drinker-vs-Weekly Drinker
8.271000E-01
Daily Drinker-vs-Occasional Drinker
2.063000E-01
Daily Drinker-vs-Social Drinker
1.756830E-01
Weekly Drinker-vs-Occasional Drinker
1.593010E-01
Weekly Drinker-vs-Social Drinker
1.202420E-01
Occasional Drinker-vs-Social Drinker
9.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.466800E-01
Normal-vs-Grade 2
1.935520E-02
Normal-vs-Grade 3
4.080400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.383200E-03
Grade 1-vs-Grade 3
9.608100E-02
Grade 1-vs-Grade 4
2.466800E-01
Grade 2-vs-Grade 3
3.346000E-01
Grade 2-vs-Grade 4
1.935520E-02
Grade 3-vs-Grade 4
4.080400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.035600E-01
Normal-vs-NonDiabetic
3.293800E-01
Diabetic-vs-NonDiabetic
3.752600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.813200E-01
Normal-vs-NoPancreatitis
2.743200E-01
Pancreatitis-vs-NoPancreatitis
2.082600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.670590E-01
Normal-vs-N1
4.820400E-01
N0-vs-N1
1.307960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.696000E-01
Normal-vs-TP53-NonMutant
2.785400E-01
TP53-Mutant-vs-TP53-NonMutant
1.510240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
